Major coexpression of κ-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles

Synapse

Volumn 42, Issue 3, 2001, Pages 185-192

  Svingos, Adena L ^a   Chavkin, Charles ^a   Colago, Eric E O ^a   Pickel, Virginia M ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Electron microscopy; Immunocytochemistry; Opiate; Psychostimulants; Sensitization; Ventral striatum

Indexed keywords

ANTIGEN; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; KAPPA OPIATE RECEPTOR; PEROXIDASE; PSYCHOSTIMULANT AGENT;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL ULTRASTRUCTURE; CORPUS STRIATUM; DENDRITIC SPINE; DRUG SENSITIZATION; ELECTRON MICROSCOPY; IMMUNOCYTOCHEMISTRY; IMMUNOGOLD STAINING; IMMUNOREACTIVITY; NERVE ENDING; NERVE FIBER; NONHUMAN; NUCLEUS ACCUMBENS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYNAPSE VESICLE;

ANIMALS; AXONS; CELL MEMBRANE; DENDRITES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, IMMUNOELECTRON; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; RATS; RECEPTORS, OPIOID, KAPPA;

EID: 0035889678     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10005     Document Type: Article

References (60)

1. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593
2. Agonist-induced phosphorylation of the kappa-opioid receptor
3. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats
4. Light microscopic morphometric analysis of peroxisomes by automatic image analysis: Advantages of immunostaining over the alkaline DAB method
5. 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells
6. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding
7. Dynorphin is a specific endogenous ligand of the κ opioid receptor
8. The dopamine transporter: Immuno chemical characterization and localization in brain
9. 2 receptor within GABAergic neurons of the rat striatum
10. Differential involvement of ventral tegmental mu, delta, and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies
11. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
12. Kappa opioid receptor-like immunoreactivity in guinea pig brain: Ultrastructural localization in presynaptic terminals in hippocampal formation
13. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals
14. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
15. κ-opioid inhibition of morphine and cocaine self-administration in rats
16. Dual ultrastructural localization of μ-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens
17. The kappaopioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum
18. U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine
19. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat
20. Development of behavioral sensitization to cocaine: Influence of kappa-opioid receptor agonists
21. Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine
22. Synaptic organization of immunocytochemically identified GABA neurons in the monkey sensory-motor cortex
23. Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes
24. Use of avidin-biotin-peroxidase complex (ABC) immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
25. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals
26. Cellular and molecular mechanisms of drug dependence
27. Electron microscopic pre-embedding double immunostaining methods
28. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats
29. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain
30. Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens
31. Kappa opioid receptor immunoreactivity is present in cells and fibers of the rat forebrain
32. Effects of cocaine and repeated cocaine followed by withdrawal: Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition
33. Kappa opioid receptor immunore activity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons
34. Voltage dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro
35. Effects of kappa opioids on cocaine self-administration by rhesus monkeys
36. Immunocytochemical localization of the alpha 1 and beta 2/3 subunits of the GABAA receptor in relation to specific GABAergic synapses in the dentate gyrus
37. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine
38. Substance P in the rat nucleus accumbens: Ultrastructural localization in axon terminals and their relation to dopaminergic afferents
39. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine
40. Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum
41. The use of lead citrate at high pH as an electronopaque stain in electron microscopy
42. U69593, a kappaopioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug seeking
43. Sympathetic axons and nerve terminals: The protein composition of small and large dense-core and of a third type of vesicles
44. Sensitization to the behavioral effects of cocaine: Modulation by dynorphin and κ-opioid receptor agonists
45. κ-opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine
46. Sensitization to the conditioned rewarding effects of morphine and cocaine: Differential effects of the kappa-opioid receptor agonist U69593
47. L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells
48. Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine
49. The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study
50. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
51. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior
52. Cellular sites for dynorphin activation of κ-opioid receptors in the rat nucleus accumbens shell
53. The vesicular acetylcholine transporter in the rat nucleus accumbens shell: Subcellular distribution and association with μ-opioid receptors
54. κ-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine
55. Dynorphin-immunoreactive neurons in the rat nucleus accumbens: Ultrastructure and synaptic input from terminals containing substance P and/or dynorphin
56. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus
57. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs
58. Neurobiology of cocaine abuse